Regenerative Medical Technology Group Inc.
RMTG
$0.03
$0.0027.14%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 66.99% | 145.42% | 52.49% | 119.51% | 3.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.99% | 145.42% | 52.49% | 119.51% | 3.92% |
| Cost of Revenue | 69.52% | 193.47% | 21.73% | 147.81% | -0.56% |
| Gross Profit | 65.89% | 125.44% | 65.91% | 107.60% | 6.00% |
| SG&A Expenses | 31.83% | 32.78% | 49.67% | 1.63% | 4.02% |
| Depreciation & Amortization | -32.38% | -128.69% | -10.03% | 43.35% | 35.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.77% | 50.71% | 33.87% | 24.57% | 4.74% |
| Operating Income | 265.04% | 388.19% | 131.73% | 55.48% | -13.61% |
| Income Before Tax | 61.24% | -149.30% | 84.85% | -2.29% | -17.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 61.24% | -149.30% | 84.85% | -2.29% | -17.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.24% | -149.30% | 84.85% | -2.29% | -17.41% |
| EBIT | 265.04% | 388.19% | 131.73% | 55.48% | -13.61% |
| EBITDA | 3,624.53% | 1,320.33% | 332.05% | 70.92% | 65.36% |
| EPS Basic | 61.40% | -147.09% | 84.96% | -1.90% | -16.99% |
| Normalized Basic EPS | 61.37% | 64.11% | 49.20% | -1.86% | -16.79% |
| EPS Diluted | 61.40% | -147.09% | 84.96% | -1.90% | -16.99% |
| Normalized Diluted EPS | 61.37% | 64.11% | 49.20% | -1.86% | -16.79% |
| Average Basic Shares Outstanding | 0.36% | 0.66% | 0.76% | 0.40% | 0.40% |
| Average Diluted Shares Outstanding | 0.36% | 0.66% | 0.76% | 0.40% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |